In recent years, a large number of clinical studies on the impact of ASXL1 mutations in PMF have been reported, some of which have revealed that ASXL1 mutations may be related to the prognosis of PMF and leukemia transformation, but its exact role remains controversial. Here, ASXL1 is linked to leukemia.